SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
885<i>They made the point in the CC that they had been constrained by fiscal nigel bates-10/8/2003
884What struck me as strange was that the participants on 25 mg generally seen seemIcebrg-10/8/2003
883I haven't listened to the CC, so sorry to post out of ignorance. What doekeokalani'nui-10/8/2003
882They made the point in the CC that they had been constrained by fiscal concerns Biomaven-10/8/2003
881IL-1 Trap Phase II Trial Misses; Regeneron Still Behind Drug By Kim Coghill WaIcebrg-10/8/2003
880ZUDIJA = <<I take it that is Croatian for "remarkably good at lookingMiljenko Zuanic-10/7/2003
879Regeneron Shares Drop on Arthritis-Drug Study Results Dow Jones, Tuesday, Omopgcw-10/7/2003
878<i> ZUDIJA </i> I take it that is Croatian for "remarkably goonigel bates-10/7/2003
877Debacle after debacle, after debacle,.... Insiders at REGN = ZUDIJA, after ZUDIMiljenko Zuanic-10/7/2003
876trading down $2 in pre-market on the news (eom)mopgcw-10/7/2003
875Regeneron Reports Phase II Results for IL-1 Trap Clinical Program in Rheumatoid nigel bates-10/7/2003
874From Tuck. [Pathway (=targets) for pulmonary hypertension] >>Published onMiljenko Zuanic-9/25/2003
873Thanks, it is mostly EGF! He is in favor of ABX-EGF. MiljenkoMiljenko Zuanic-9/20/2003
872Haven't listened to it, but there's a fresh "VEGF Inhibitors" scaram(o)uche-9/20/2003
871respond at BV: Message 19288314 Press Release Source: Regeneron PharmaceuticalsMiljenko Zuanic-9/9/2003
870<<Did you buy more calls or stock of regn when it retreated to the 12.5 reMiljenko Zuanic-9/8/2003
869That really is a sweet deal. REGN is now my third biggest holding (after SEPR Biomaven-9/8/2003
868Share of development costs repaid on <i>profitability</i>. Sweeeet.keokalani'nui-9/8/2003
867Indeed! And as promised per your request, I've sold 30% of my original posiSpartex-9/8/2003
866Bingo! :) [eom]Miljenko Zuanic-9/8/2003
865Aventis and Regeneron Enter Global Partnership to Develop and Commercialize the scaram(o)uche-9/8/2003
864Press Release Source: Genentech Genentech Presents Positive Preliminary Six-MoMiljenko Zuanic-8/18/2003
863<< 2. Revenue from Novartis collaboration? No draw from loan facility and Miljenko Zuanic-8/14/2003
862If the speed of the IL-4/13-Trap is the same as for VEGF-T, maybe somewhere in 2Miljenko Zuanic-8/3/2003
861<<Key paragraph from the release: …***Regeneron is considering a number ofMiljenko Zuanic-8/1/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News